Evidence map›Paper›PMID 39516877›Full record

ArticleCell communication and signaling : CCS2024

Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity.

Valentina Salvi, Carolina Gaudenzi, Barbara Mariotti, Gaia Giongrandi, Silvia Alacqua, Veronica Gianello, Tiziana Schioppa, Laura Tiberio, Angela Ceribelli, Carlo Selmi and 6 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations.Clinical, cosmetic and investigational dermatology · 2026
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Valentina SalviDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Carolina GaudenziDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Barbara MariottiDepartment of Medicine, University of Verona, Verona, Italy.
Gaia GiongrandiDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Silvia AlacquaDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Veronica GianelloDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Tiziana SchioppaDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Laura TiberioDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Angela CeribelliDepartment of Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
Carlo SelmiDepartment of Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
Paolo BergeseDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Stefano CalzaDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Annalisa Del PreteDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Silvano SozzaniDepartment of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Institute Pasteur-Italia, Rome, Italy.
Flavia BazzoniDepartment of Medicine, University of Verona, Verona, Italy.
Daniela BosisioDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy. daniela.bosisio@unibs.it.

Funding

Ministero dell'Università e della Ricerca 2022PYH73KMinistero dell'Università e della Ricerca P2022L3LJNMinistero dell'Università e della Ricerca PNRR-CN3Università degli Studi di Brescia Fondi locali
6 · The paper itself

Abstract

backgroundThe physiological relevance of cell-to-cell communication mediated by small extracellular vesicle-encapsulated microRNAs (sEV-miRNAs) remains debated because of the limiting representativity of specific miRNAs within the extracellular pool. We hypothesize that sEV-miRNA non-canonical function consisting of the stimulation of Toll-like receptor 7 (TLR7) may rely on a global shift of the sEV cargo rather than on the induction of one or few specific miRNAs. Psoriasis represents an ideal model to test such hypothesis as it is driven by overt activation of TLR7-expressing plasmacytoid dendritic cells (pDCs) following keratinocyte damage.

methodsTo mimic the onset of psoriasis, keratinocytes were treated with a cocktail of psoriatic cytokines or UV-irradiated. SmallRNA sequencing was performed on sEVs released by healthy and UV-treated keratinocytes. sEV-miRNAs were analyzed for nucleotide composition as well as for the presence of putative TLR7-binding triplets. Primary human pDCs where stimulated with sEVs +/- inhibitors of TLR7 (Enpatoran), of sEV release (GW4869 + manumycin) and of TLR7-mediated pDC activation (anti-BDCA-2 antibody). Secretion of type I IFNs and activation of CD8

resultssEV-miRNAs released by damaged keratinocytes revealed a significantly higher content of TLR7-activating sequences than healthy cells. As expected, differential expression analysis confirmed the presence of miRNAs upregulated in psoriatic skin, including miR203a. More importantly, 76.5% of induced miRNAs possessed TLR7-binding features and among these we could detect several previously demonstrated TLR7 ligands. In accordance with this in silico analysis, sEVs from damaged keratinocytes recapitulated key events of psoriatic pathogenesis by triggering pDCs to release type I interferon and activate cytotoxic CD8 DISCUSSION: Our results demonstrate that miR203a is just one paradigmatic TLR7-activating miRNA among the hundreds released by UV-irradiated keratinocytes, which altogether trigger pDC activation in psoriatic conditions. This represents the first evidence that cell damage shifts the miRNA content of sEVs towards a TLR7-activating cargo capable to propagate inflammation and immunity, offering strong support to the physiological role of systemic miRNA-based cell-to-cell communication.

Indexed as

Extracellular VesiclesInflammationKeratinocytesMicroRNAsToll-Like Receptor 7Dendritic CellsHumansImmunityPsoriasisUltraviolet RaysMicroRNAsTLR7 protein, humanToll-Like Receptor 7ExosomesExtracellular vesicleshsa-miR203a-3pIFN-αIFN-γIL-6Plasmacytoid dendritic cells (pDCs)PsoriasisTNF-αToll-like receptor 7 (TLR7)

Identifiers

PMID39516877
PMCPMC11545887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.